1. Home
  2. HWC vs TVTX Comparison

HWC vs TVTX Comparison

Compare HWC & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hancock Whitney Corporation

HWC

Hancock Whitney Corporation

N/A

Current Price

$75.79

Market Cap

5.6B

Sector

Finance

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$57.27

Market Cap

5.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HWC
TVTX
Founded
1883
N/A
Country
United States
United States
Employees
3658
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.3B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
HWC
TVTX
Price
$75.79
$57.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
13
Target Price
$77.67
$40.62
AVG Volume (30 Days)
937.0K
1.3M
Earning Date
04-21-2026
05-04-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
92.89
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.59
$44.76
Revenue Next Year
$4.42
$35.51
P/E Ratio
$12.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.05
$15.03
52 Week High
$79.36
$60.10

Technical Indicators

Market Signals
Indicator
HWC
TVTX
Relative Strength Index (RSI) 57.37 57.88
Support Level $73.03 $53.93
Resistance Level $79.36 $59.89
Average True Range (ATR) 1.41 2.58
MACD -0.29 -0.40
Stochastic Oscillator 50.59 58.73

Price Performance

Historical Comparison
HWC
TVTX

About HWC Hancock Whitney Corporation

Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business, and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit, and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations, and individuals and provides its customers access to investment advisory and brokerage products.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: